JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8556 GSK2126458
1 Citation

Target: PI3K|mTOR

Summary: PI3K/mTOR inhibitor

≥25.3 mg/mL
A8617 CCT128930 HCl

Target: Akt

Summary: AKT inhibitor

insoluble in H2O; ≥17.1 mg/mL
A8628 Chloroquine diphosphate
16 Citation

Target: Autophagy

Summary: Antimalarial drug, TLR7 and TLR9 inhibitor

insoluble in DMSO; insoluble in EtOH; ≥106.06 mg/mL
A8659 SANT-1
2 Citation

Summary: Shh inhibitor,potent and cell-permeable

insoluble in H2O; insoluble in EtOH; ≥18.75 mg/mL
B3041 BTB06584

Target: F1 Fo-ATPase

Summary: F1F0 ATP synthases

≥17.05 mg/mL
B1402 GZD824

Target: Bcr-Abl

Summary: Bcr-Abl inhibitor,novel orally bioavailable

≥36.25 mg/mL
B1499 RVX-208
2 Citation

Summary: Potent BET bromodomain inhibitor

insoluble in H2O; ≥18.52 mg/mL
B3272 Inauhzin

Target: Sir2-like Family Deacetylases (Sirtuins)

Summary: SIRT1 inhibitor

≥23.5 mg/mL
B1526 Tandutinib (MLN518)

Summary: FLT3 inhibitor,potent and selective

≥17.85 mg/mL
B1032 VU0152100

Summary: M4 receptor allosteric modulators

Soluble in DMSO